Twenty‐Four‐Hour Post‐Thrombolysis NIHSS Score As the Strongest Prognostic Predictor After Acute Ischemic Stroke: ENCHANTED Study

Author:

You Shoujiang1ORCID,Wang Yanan23ORCID,Wang Xia3ORCID,Maeda Toshiki34ORCID,Ouyang Menglu3ORCID,Han Qiao5,Li Qiang3,Song Lili3ORCID,Zhao Yang3,Chen Chen36ORCID,Delcourt Candice37ORCID,Ren Xinwen3ORCID,Carcel Cheryl3ORCID,Zhou Zien3ORCID,Cao Yongjun1ORCID,Liu Chun‐Feng1ORCID,Zheng Danni3,Arima Hisatomi4ORCID,Robinson Thompson G.8ORCID,Chen Xiaoying3ORCID,Lindley Richard I.39ORCID,Chalmers John3ORCID,Anderson Craig S.31011ORCID

Affiliation:

1. Department of Neurology and Clinical Research Center of Neurological Disease The Second Affiliated Hospital of SooChow University Suzhou China

2. Department of Neurology, West China Hospital Sichuan University Chengdu Sichuan China

3. The George Institute for Global Health, Faculty of Medicine University of New South Wales Sydney NSW Australia

4. Department of Preventive Medicine and Public Health Fukuoka University Fukuoka Japan

5. Department of Neurology Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine Suzhou China

6. Department of Neurology, Shanghai East Hospital, School of Medicine Tongji University Shanghai China

7. Department of Clinical Medicine, Faculty of Medicine, Health and Human Sciences Macquarie University Sydney NSW Australia

8. Department of Cardiovascular Sciences and NIHR Leicester Biomedical Research Centre University of Leicester Leicester UK

9. Westmead Clinical School University of Sydney Camperdown NSW Australia

10. The Institute of Science and Technology for Brain‐inspired Research Fudan University Shanghai China

11. Neurology Department Royal Prince Alfred Hospital Sydney NSW Australia

Abstract

Background This study was conducted to determine optimal predictive ability of National Institutes of Health Stroke Scale (NIHSS) measurements at baseline, 24 hours, and change from baseline to 24 hours after thrombolysis on functional recovery in patients with acute ischemic stroke who participated in the ENCHANTED (Enhanced Control of Hypertension and Thrombolysis Stroke Study). Methods and Results ENCHANTED was an international, multicenter, 2×2 quasifactorial, prospective, randomized open trial of low‐dose versus standard‐dose intravenous alteplase and intensive versus guideline‐recommended blood pressure lowering in thrombolysis‐eligible patients with acute ischemic stroke. Absolute (baseline minus 24 hours) and percentage (absolute change/baseline × 100) changes in NIHSS scores were calculated. Receiver operating characteristic curve analyses assessed performance of different NIHSS measurements on 90‐day favorable functional recovery (modified Rankin Scale [mRS] score 0–2) and excellent functional recovery (mRS score 0–1). Youden index was used to identify optimal predictor cutoff points. A total of 4410 patients in the ENCHANTED trial were enrolled. The 24‐hour NIHSS score had the highest discriminative ability for predicting favorable 90‐day functional recovery (mRS score 0–2; area under the curve 0.866 versus 0.755, 0.689, 0.764; P <0.001) than baseline, absolute, and percentage change of NIHSS score, respectively. The optimal cutoff point of 24‐hour NIHSS score for predicting favorable functional recovery was ≤4 (sensitivity 66.5%, specificity 87.1%, adjusted odds ratio, 9.44 [95% CI, 7.77–11.48]). The 24‐hour NIHSS score (≤3) was the best predictor of 90‐day excellent functional recovery (mRS score 0–1). Findings were consistent across subgroups, including sex, race, baseline NIHSS score, stroke subtype, and age. Conclusions In thrombolysis‐eligible patients with acute ischemic stroke, 24‐hour NIHSS score (optimal cutpoint of 4) is the strongest predictor of 90‐day functional recovery over baseline and early change of NIHSS score. Registration URL: https://clinicaltrials.gov . Unique Identifier: NCT01422616.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3